Health Canada

The Valens Company and A1 Cannabis Launch Two New Summit 10 Beverage Flavours

Thursday, August 5, 2021 - 10:00pm

Summit 10 Raspberry Lemonade and Summit 10 Peach Lemonade are now available in British Columbia, with Alberta to follow later this summer

Key Points: 
  • Summit 10 Raspberry Lemonade and Summit 10 Peach Lemonade are now available in British Columbia, with Alberta to follow later this summer
    Previously launched Summit 10 Lemonade Iced Tea ranked among top three cannabis-infused beverage SKUs in participating Canadian markets for the period May 1, 2021, to July 31, 2021*
    KELOWNA, BC, Aug. 5, 2021 /PRNewswire/ - The Valens Company Inc.(TSX: VLNS) (OTCQX: VLNCF) (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis products,today launched two new flavours of the top-selling Summit 10 beverage in partnership with A1 Cannabis Company ("A1 Cannabis" or "A1").
  • Summit 10 Raspberry Lemonade and Summit 10 Peach Lemonade will be available as part of the Summit product lineup of THC-forward beverages and edibles.
  • The Company provides proprietary cannabis processing services, in addition to best-in-class product development, manufacturing, and commercialization of cannabis consumer packaged goods.
  • Nothing herein should be construed as either an offer to sell or a solicitation to buy or sell securities of The Valens Company.

eSight recognized as a 2021 Best Workplace™ in Manufacturing

Thursday, August 5, 2021 - 4:00pm

TORONTO, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Leading vision-enhancement platform, eSight , today announces the organization has been named on the 2021 list of Best Workplaces in Manufacturing, which surveys employees and honours companies with outstanding company culture.

Key Points: 
  • TORONTO, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Leading vision-enhancement platform, eSight , today announces the organization has been named on the 2021 list of Best Workplaces in Manufacturing, which surveys employees and honours companies with outstanding company culture.
  • Our motivation to change lives is at the heart of everything we do at eSight.
  • The company created the eSight Workplace program to provide its medical devices to visually impaired workers, along with training.
  • Great Place to Work provides the benchmarks, framework, and expertise needed to create, sustain, and recognize outstanding workplace cultures.

Jimmy Placa of Davion Inc. Wins EY Entrepreneur of the Year 2021 New Jersey Award

Thursday, August 5, 2021 - 4:03pm

Ernst & Young LLP (EY US) announced that Jimmy Placa of Davion Inc. was named an Entrepreneur Of The Year 2021 New Jersey Award winner.

Key Points: 
  • Ernst & Young LLP (EY US) announced that Jimmy Placa of Davion Inc. was named an Entrepreneur Of The Year 2021 New Jersey Award winner.
  • Jimmy Placa was selected by an independent panel of judges and the award was announced during the programs awards gala.
  • Winning the Entrepreneur of the Year 2021 New Jersey Award among so many talented and deserving entrepreneurs is a tremendous honor.
  • As a New Jersey award winner, Mr. Placa is now eligible for consideration for the Entrepreneur Of The Year 2021 National Awards.

Pure Extracts Ships Initial Edible Cannabis Gummies Order to British Columbia

Thursday, August 5, 2021 - 1:50pm

VANCOUVER, British Columbia, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (Pure Extracts or the Company), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging psychedelic sector, is pleased to announce that its wholly owned subsidiary, Pure Extracts Manufacturing Corp., has shipped its initial order of edible cannabis gummies via its distribution partner to the British Columbia Liquor Distribution Branch (LDB).

Key Points: 
  • VANCOUVER, British Columbia, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (Pure Extracts or the Company), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging psychedelic sector, is pleased to announce that its wholly owned subsidiary, Pure Extracts Manufacturing Corp., has shipped its initial order of edible cannabis gummies via its distribution partner to the British Columbia Liquor Distribution Branch (LDB).
  • We are excited to have shipped our first order for Fire Burst cinnamon flavoured Pure Chews to the LDB, the wholesaler serving our home province of British Columbia, said Ben Nikolaevsky, CEO.
  • The edible gummie business is a material revenue producer for Pure Extracts.
  • at https://www.bccannabisstores.com/
    Pure Extracts Technology Corp. features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia.

Cannabis Companies Prepare for Explosive Growth Following Federal US Legalization

Thursday, August 5, 2021 - 1:50pm

As both state and federal governments move closer to legalizing cannabis, companies within this sector are also laying the groundwork and pursuing initiatives to gather a market share within the cannabis industry.

Key Points: 
  • As both state and federal governments move closer to legalizing cannabis, companies within this sector are also laying the groundwork and pursuing initiatives to gather a market share within the cannabis industry.
  • The company also expects to take delivery orders from other companies later in the year after thoroughly testing its systems.
  • The company also anticipates that the continued state-to-state cannabis legalization will expand its market for the Affinity System.
  • This transaction sets Sundial as one of Canada's largest vertically integrated cannabis companies and gives the company a strategic entry into the cannabis retail sector.

Cannabis Companies Prepare for Explosive Growth Following Federal US Legalization

Thursday, August 5, 2021 - 1:50pm

NEW YORK, Aug. 5, 2021 /PRNewswire/ -- At least 18 states in America have legalized recreational marijuana and 37 have legalized different forms of medical marijuana thanks to the growing push for legalization at the state and federal levels. If passed, the Marijuana Opportunity Reinvestment and Expungement (MORE) Act would remove marijuana from the Controlled Substances Act where it is listed as a Schedule I drug. As both state and federal governments move closer to legalizing cannabis, companies within this sector are also laying the groundwork and pursuing initiatives to gather a market share within the cannabis industry. Sixth Wave Innovations Inc. (OTCQB:SIXWF) (CSE:SIXW), Neptune Wellness Solutions (NASDAQ:NEPT) (TSX:NEPT), Canopy Growth Corp (NASDAQ:CGC) (TSX:WEED), Sundial Growers Inc. (NASDAQ:SNDL), and GrowGeneration Corp (NASDAQ:GRWG) are among the companies capitalizing on the growing push for legalization and the increased demand for cannabis products.

Key Points: 
  • As both state and federal governments move closer to legalizing cannabis, companies within this sector are also laying the groundwork and pursuing initiatives to gather a market share within the cannabis industry.
  • The company also expects to take delivery orders from other companies later in the year after thoroughly testing its systems.
  • The company also anticipates that the continued state-to-state cannabis legalization will expand its market for the Affinity System.
  • This transaction sets Sundial as one of Canada's largest vertically integrated cannabis companies and gives the company a strategic entry into the cannabis retail sector.

ZYUS Life Sciences Launches Two New Topical Cannabinoid Formulations for Direct to Patient Sales in Canada

Thursday, August 5, 2021 - 12:35pm

ZYUS Life Sciences Inc. ("ZYUS"), a Canadian-based life sciences company leading scientific research and development in phyto-therapeutics, announced today that the company has launched two new topical cannabinoid formulations for direct sales and distribution to registered medical patients in Canada.

Key Points: 
  • ZYUS Life Sciences Inc. ("ZYUS"), a Canadian-based life sciences company leading scientific research and development in phyto-therapeutics, announced today that the company has launched two new topical cannabinoid formulations for direct sales and distribution to registered medical patients in Canada.
  • ZYUS places the utmost importance on ensuring our products are high-quality, consistent, and always available for the patients we serve.
  • Expanding the existing ZYUS product offerings of cannabinoid oil formulations, the new topical cream formulations are available for direct sales and distribution to registered medical patients.
  • About ZYUS Life Sciences Inc.
    ZYUS is a Canadian-based life sciences company focused on the global development and commercialization of innovative cannabinoid-based therapeutics and product candidates.

Diagnos A.I. retinal screening technology expands into international markets

Thursday, August 5, 2021 - 6:00am

CARA's artificial intelligence-based image enhancement algorithms provide sharper, clearer, retinal images that can then be analyzed for anomalies.

Key Points: 
  • CARA's artificial intelligence-based image enhancement algorithms provide sharper, clearer, retinal images that can then be analyzed for anomalies.
  • "IRIS continues to be at the forefront of implementing technology driven solutions for clinical optometry and optical retail," stated said Eric Babin, President of IRIS.
  • "Artificial intelligence will raise our standard when it comes to quality of care and we are eager to collaborate with Diagnos."
  • Diagnos' technology can inform a patient that she is at risk for a heart attack or stroke.

New poll shows a strong base of Canadians overwhelmingly support controlled legal access to psilocybin-assisted therapy; Canadian Psychedelic Association responds with Memorandum of Regulatory Approval (MORA)

Wednesday, August 4, 2021 - 12:02pm

With public support at an all-time high, the CPA will now focus on introducing evidence-informed regulations to officials at Health Canada.

Key Points: 
  • With public support at an all-time high, the CPA will now focus on introducing evidence-informed regulations to officials at Health Canada.
  • Dr. Kryskow has witnessed firsthand what legal access to psychedelic medicine can do for Canadians in need of new treatment options.
  • Cory Firth, the Executive Director of the Canadian Psychedelic Association is confident the proposed amendments will continue our collaborative effort with Health Canada.
  • 82% of Canadians polled support or somewhat support approval for allowing the use of psilocybin-assisted therapy.

Cybin to Commence Trading on the NYSE American on August 5

Wednesday, August 4, 2021 - 12:00pm

Cybin Inc. ( NEO:CYBN ) (OTCQB:CLXPF) (Cybin or the Company), a biotechnology company focused on progressing psychedelic therapeutics, today announced that its common shares will open for trading on the NYSE American LLC stock exchange (NYSE American) on August 5, 2021, under the symbol CYBN.

Key Points: 
  • Cybin Inc. ( NEO:CYBN ) (OTCQB:CLXPF) (Cybin or the Company), a biotechnology company focused on progressing psychedelic therapeutics, today announced that its common shares will open for trading on the NYSE American LLC stock exchange (NYSE American) on August 5, 2021, under the symbol CYBN.
  • In addition to listing and trading on the NYSE American in U.S. dollars, Cybins common shares will continue to be listed and trade in Canada on the NEO Exchange (NEO) in Canadian dollars under the symbol CYBN.
  • Shareholders are advised to contact their broker for more information if they have questions in this regard.
  • Forward-looking statements in this news release include statements regarding the commencement of trading on the NYSE American, the continued listing on the NEO, the cease of quotation on the OTC markets and the continued trading on the Frankfurt Stock Exchange.